ST8SIA2 and neuroblastoma: The authors optimized a quantitative RT-PCR in order to evaluate STX expression in tumor samples, cell lines, and bone marrow from a cohort of high-risk NB patients enrolled in a post-induction immunotherapy protocol utilizing anti-GD2 antibody 3F8.